Search results
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
WJET - WFXP Erie· 6 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 5 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Research identifies an infectious language epidemic
Digital Journal· 4 days agoWhat effects did social media rhetoric have on COVID-19 infection and death rates across the U.S., and what can policymakers and public health officials...
Explainer-What are the FLiRT COVID variants and are they more contagious? By Reuters
Investing.com· 6 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
The growing promise of cancer vaccines
Cosmos· 4 days agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In...
Benzinga· 4 days agoAre they in your portfolio? First Solar, Inc. FSLR shares jumped 41.5% possibly in response to...
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells | Cornell Chronicle
Cornell News Service· 2 days agoAn interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be...
The Heroes Of Vaccine Development: Lipid Nanoparticles
BioresearchOnline· 4 days agoLipid nanoparticles (LNPs) have played a crucial role in the advancement of vaccine development,...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US By Reuters
Investing.com· 5 days agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European...
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology...
Benzinga· 2 days agoPlanegg/Martinsried, May 28, 2024 – Medigene AG (Medigene or the "Company", FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid